This table covers the classical small molecule neurotransmitters for which there is substantial published evidence that they are present, and are likely to function in specific C. elegans neurons. This evidence falls under 'criterion I' as outlined in Criteria for assigning a neurotransmitter function in C. elegans. Other molecules that may serve as neurotransmitters in C. elegans, but for which there is little or no published evidence, are generally not included here. This table also does not typically include substances released by non-neuronal cells that may act in a hormonal or transmitter-like function. [See Hobert (2013) for a presentation of 'the case for and against other neurotransmitter systems' and other transmitter-related aspects of the 'neuronal genome.'] See also Pereira et al. (2015), Gendrel et al. (2016) and Serrano-Saiz et al., 2017
for extensive treatments of neurotransmitters in C. elegans, and the Hobert lab Neurotransmitter Map Resource.
In the literature cited, there are occasional disagreements about which specific cells show expression in reporter fusion transgenics. We have preserved identifications found in a paper in this table, even for cases in which there was a likely mis-identification. (We have attempted to identify such instances in the footnotes.) In some cases, the situation is less clear, and could reflect real expression differences arising from reporter constructs with different regions of sequence, integration sites, etc. Each Summary List of neurons represents our best judgment based on the evidence available. Where conflicts arise, we have typically deferred to studies that are 1) more recent, 2) comprehensive, and/or 3) using constructs more likely to represent the true expression pattern (i.e., fosmid or insertions into native loci). Curtis M. Loera & James B. Randb aDept. of Biology, University of San Diego, San Diego, CA; bOklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Okalahoma City, OK |
Neurons currently lacking classical neurotransmitter assignments
Footnotes
Abbreviations
Acknowledgements and General References
How to cite this document
All Neurons with Neurotransmitter IDs
- Excel spreadsheet [now updated from the previous WormAtlas 2016 version]
[Note: The neuron list comes originally from Individual Neurons on WormAtlas; the tables are mostly derived with permission from the tables in Pereira et al. (2015) and Serrano-Saiz et al., 2017 supplemental materials.]
ACETYLCHOLINE (ACh) Summary List of ACh neurons | ||||
DESCRIPTION |
GENE NAME | TECHNIQUE FOR DETECTION | LOCALIZATION | REFERENCES |
ACh | NA | Radioenzymatic assay | Whole animal | Hosono et al., 1987; Hosono & Kamiya, 1991; Nguyen et al., 1995 |
Synthesis |
||||
Choline Acetyltransferase (ChAT) | cha-11 |
Enzymatic assay | Whole animal | Rand & Russell, 1984 |
ChAT | cha-11 |
Antibody | Same as unc-17 (see below)2 | Duerr et al., 2008 |
Transport | ||||
Vesicular Acetylcholine Transporter (VAChT) | unc-171 |
Antibody | AIA, AIY | Altun-Gultekin et al., 2001 |
VAChT | unc-171 |
Antibody | ALN, AS1-11, DA1-9, DB1-7, HSN(faint, h), PLN, SDQ, URA, URB, VA1-12, VB1-11, VC1-6(h), many others. | Duerr et al., 2008 |
VAChT | unc-171 |
Reporter transgenics | IL2, URA, URB | Zhang et al., 2014 |
VAChT | unc-171 |
Reporter transgenics | PCB(m), PCC(m), PVX(m), PVY(m), SPC(m), SPV(m) | Garcia et al., 2001; LeBouef et al., 2014 |
VAChT | unc-171 |
Reporter transgenics | SMB | Kim et al., 2015 |
VAChT | unc-171 |
Reporter transgenics (fosmid3), Antibody | ADF, AIA, [AIM]4, AIN, AIY, ALN, AS1-11, ASJ, AVA, AVB, AVD, AVE, AVG5, AWB, CA1-9(m), CEM(m), DA1-9, DB1-7, DVA6, DVE(m)7, DVF(m)7, HOB(m), HSN(h), I15, I35, IL2, M15, M25, M4, M5, MC5, PCB(m), PCC(m), PDA, PDB, PDC(m), PGA(m), PLN, PVC, PVN5, PVP, PVV(m), PVX(m), PVY(m), PVZ(m), R1A(m), R2A(m), R3A(m), R4A(m), R6A(m), RIB8, RIF, RIH, RIR, RIV, RMD, RMF, RMH, SAA5, SAB, SIA, SIB, SDQ, SMB, SMD, SPC(m), SPV(m), URA, URB, URX, VA1-12, VB1-11, VC1-6(h)9 | Pereira et al., 2015 |
VAChT | unc-171 |
Reporter transgenics (fosmid3) | DX1/2(m)7 | Serrano-Saiz et al., 2017 |
Choline Transporter (HAChT / ChT) | cho-1 |
Reporter transgenics | Most cholinergic (i.e., unc-17-expressing) neurons | Okuda et al., 2000; Matthies et al., 2006; Mullen et al., 2007 |
ChT | cho-1 | Reporter transgenics | IL2, URA | Zhang et al., 2014 |
ChT | cho-1 | Reporter transgenics (fosmid3) | Expressed in all unc-17-expressing neurons EXCEPT AVG, CA7-9(m), DX1/2(m)7, HSN(h), I1, I3, M1, M2, MC, PVN, SAA, and VC4-5(h); also expressed in R8A(m), R8B(m) | Pereira et al., 2015; Serrano-Saiz et al., 2017 |
ChT | cho-1 | Uptake assay10 | NA - heterologous expression (Xenopus oocyte) | Okuda et al., 2000 |
Postsynaptic Choline/Acetylcholine Transporter | snf-6 |
Reporter transgenics | Neuromuscular junctions of body wall muscle, vulval and enteric muscles; a few unidentified neurons | Kim et al., 2004 |
Catabolism |
||||
Acetylcholinesterase (AChE) Total | NA | Histochemistry11 | Strong, reliable staining in nerve ring, ventral ganglion, pharyngeal-intestinal valve and anal depressor region; more variable staining in VNC, DNC and PAG | Culotti et al., 1981 |
AChE class A | ace-1 |
Enzymatic assay | Whole animal | Johnson et al., 1981 |
AChE class B | ace-2 |
Enzymatic assay | Whole animal | Johnson et al., 1981; Culotti et al., 1981 |
AChE class C | ace-3 |
Enzymatic assay | Whole animal | Kolson et al., 1985a; Kolson et al., 1985b; Johnson et al., 1988 |
AChE | ace-1 |
Reporter transgenics | CEP, OLL, pm5, body wall muscles, vulval muscles, anal sphincter muscle | Culetto, 1999 |
AChE | ace-1 |
Reporter transgenics (fosmid3) | CEP, OLL | Pereira et al., 2015 |
AChE | ace-2 |
Reporter transgenics | IL cells, AWB(?), AWC, additional head neurons, pm5, PVC, PVQ, PDA, hyp 8-11 | Combes et al., 2003 |
AChE | ace-2 |
Reporter transgenics (fosmid3) | AS1-11, AVA, AVB, AVD, AVE, DA1-9, DB1-7, DVA, M4, PDA, RIH, VA1-12, VB1-11, others | Pereira et al., 2015 |
AChE | ace-3/ace-412 |
Reporter transgenics | pm3, pm4, pm5, pm7, CAN, some body muscles | Combes et al., 2003 |
AChE | ace-3/ace-412 | Reporter transgenics | AIA, DVA, IL2, PDA, RIH, RIV, RMD, SIA, SMD, URA, URB, URX, others | Pereira et al., 2015 |
Related Mutant Phenotypes / Other Supportive Evidence | ||||
ACh | cha-1 |
ACh levels reduced or absent | Hosono et al., 1987 | |
ACh | unc-17 |
ACh levels elevated | Hosono et al., 1987 | |
ChAT | cha-1 |
ChAT enzymatic activity is reduced or absent; hypomorphic cha-1 mutants are Unc and Ric (resistant to inhibitors of cholinesterase); null mutants arrest shortly after hatching (lethal). | Rand & Russell 1984; Hosono et al., 1987; Rand, 1989 | |
VAChT | unc-17 |
Hypomorphic unc-17 mutants are Unc and Ric; null mutants arrest shortly after hatching (lethal). | Brenner, 1974; Rand & Russell 1984; Alfonso et al., 1993 | |
VAChT | unc-17 |
Mutant analysis indicates cholinergic function in pharyngeal neuron MC. | Raizen et al., 1995 | |
VAChT | unc-17 |
Mutant analysis indicates cholinergic function in neuron IL2. | Lee et al., 2012 | |
AChE | ace-1 | Class A - AChE activity is absent. ace-1 mutants have no behavioral phenotype. | Johnson et al., 1981 | |
AChE | ace-2 | Class B - AChE activity is absent. Histochemical staining4 is reduced in ace-2 mutants, and completely eliminated in ace-2; ace-1 double mutants. ace-2 mutants have no behavioral phenotype, but ace-2; ace-1 double mutants are Unc. | Culotti et al., 1981 | |
AChE | ace-3 | Class C- AChE activity is absent. ace-3 mutants have no behavioral phenotype; ace-3; ace-1 and ace-2 ; ace-3 double mutants have ~wild type behavior; ace-2 ; ace-3; ace-1 triple mutants arrest as L1s (lethal). | Johnson et al., 1988 | |
SUMMARY - Cholinergic Neurons (adult): Hermaphrodite (n = 160), Male (n = 193)
By Class: By Class (with numbers and notes): Head: ADF(2), AIA(2), AIM(2)4, AIN(2), AIY(2), AS1, ASJ(2), AVA(2), AVB(2), AVD(2), AVE(2), AVG5, AWB(2), CEM(4, m), DA1, DB1-2, IL2(6), RIB(2)8, RIF(2), RIH, RIR, RIV(2), RMD(6), RMF(2), RMH(2), SAA(4)5, SAB(3), SIA(4), SIB(4), SMB(4), SMD(4), URA(4), URB(2), URX(2), VA1, VB1-2 Pharynx: I1(2)5, I35, M15, M2(2)5, M4, M5, MC(2)5 Ventral nerve cord & body: AS2-10, CAn(1-9)(m)4, DA2-7, DB3-7, HSN(2, h), SDQ(2), VA2-11, VB3-11, VC1-6(h) Tail: ALN(2), AS11, DA8-9, DVA6, DX1(m)7, DX2(m)7, HOB(m), PCB(2, m), PCC(2, m), PDA, PDB, PDC(m)8, PGA(m)8, PLN(2), PVC(2), PVN(2)5, PVP(2), PVV(m), PVX(m), PVY(m), PVZ(m), R1A(2, m), R2A(2, m), R3A(2, m), R4A(2, m), R6A(2, m), SPC(2, m), SPV(2, m), VA12 Note: Somas found in the retrovesicular ganglion (RVG) are listed in the head; those in the preanal ganglion (PAG) are listed in the tail. |
DOPAMINE (3-hydroxytyramine, dihydroxyphenylethylamine) Summary List of Dopaminergic neurons | ||||||
DESCRIPTION |
GENE NAME | TECHNIQUE FOR DETECTION | LOCALIZATION | REFERENCES | ||
Dopamine | NA | HPLC + ED | Whole animal | Sanyal et al., 2004 | ||
Dopamine | NA | Formaldehyde induced fluorescence (FIF) | CEP, ADE, PDE, R5A(m), R7A(m), R9A(m) | Sulston et al., 1975 | ||
Synthesis |
||||||
Tyrosine Hydroxylase (TH) | cat-2 |
Reporter transgenics | CEP, ADE, PDE, R5A(m), R7A(m), R9A(m), |
Lints & Emmons, 1999; Flames & Hobert, 2009 ; LeBouef et al., 2014 | ||
Aromatic L-Amino Acid Decarboxylase (AADC)14 | bas-1 |
Reporter transgenics | CEP, ADE, PDE, R5A(m), R7A(m), R9A(m), |
Hare & Loer, 2004; Flames & Hobert, 2009 ; LeBouef et al., 2014 | ||
BH4 Cofactor Synthesis and Regeneration
|
||||||
GTP |
cat-4 |
Reporter transgenics | CEP, ADE, PDE, R5A(m), R7A(m), R9A(m); see also 5HT neurons | Sze et al., 2002; Flames & Hobert, 2009 | ||
GTPCH1 | cat-4 |
Enzymatic assay | Whole animal | Loer et al., 2015 | ||
Pyruvoyl Tetrahydropterin Synthase (PTPS) | ptps-116 |
Reporter transgenics | various unidentified neurons and non-neuronal cells; see also 5HT neurons | Zhang et al., 2014; Loer et al., 2015 | ||
PTPS | ptps-1 | Enzymatic assay | Whole animal | Loer et al., 2015 | ||
Pterin Carbinolamine Dehydratase (PCBD) | pcbd-116 |
Reporter transgenics | various unidentified neurons and non-neuronal cells; see also 5HT neurons | Zhang et al., 2014; Loer et al., 2015 | ||
Quinoid Dihydropterin Reductase (QDPR)17 | qdpr-116 |
Reporter transgenics | CEP, other unidentified cells; see also 5HT neurons | Zhang et al., 2014; Loer et al., 2015 | ||
Transport | ||||||
Vesicular Monoamine Transporter (VMAT)18 | cat-1 |
Antibody19 | CEP, ADE, PDE; see also 5HT, OA, and TA neurons | Duerr et al., 1999 | ||
VMAT | cat-1 |
Reporter transgenics | CEP, ADE, PDE, R5A(m), R9A(m); see also 5HT, OA, and TA neurons | Flames & Hobert, 2009 | ||
VMAT | cat-1 |
Reporter transgenics (fosmid3) | CEP, ADE, PDE, R5A(m), R7A(m), R9A(m); see also 5HT, OA, and TA neurons | Serrano-Saiz et al., 2017 | ||
VMAT | cat-1 |
Uptake assay21 | NA - heterologous expression (CV-1 cells) | Duerr et al., 1999 | ||
(Plasma Membrane) Dopamine Transporter (DAT) | dat-1 |
Reporter transgenics | CEP, ADE, PDE, R5A(m), R7A(m), R9A(m) | Nass et al., 2001; Nass et al., 2002; Flames & Hobert, 2009 | ||
DAT | dat-1 | Antibody | CEP, ADE, PDE(rare) | McDonald et al, 2007 | ||
DAT | dat-1 |
Uptake assay22 | NA - heterologous expression (HeLa cells) | Jayanthi et al., 1998 | ||
DAT | dat-1 |
Uptake assay, patch clamping recording23 |
Heterologous expression (tsA-201 cells) and cultured embryonic C. elegans dopaminergic neurons (Pdat-1::GFP cells) | Carvelli et al., 2004 | ||
Catabolism [Note: Monoamine catabolism pathways are only partially characterized in C. elegans. N-acetylation and N-succinylation are likely significant destinations for monoamines including dopamine (Artyukhin et al., 2013). Oxidation via AMX-2/MAO is likely, similar to the well-characterized pathways in other animals (best known from vertebrates, especially mammals). There are no clear orthologs of catechol-o-methyl transferase (COMT); however, worm comt genes encode proteins with a methyltransferase associated domain also found in mammalian COMT.24 Several different monoamine inactivating modifications are found among invertebrate phyla, including N-acetylation, γ-glutamylation, β-alanylation, sulfation, etc. (see review by Sloley, 2004), although it is not always clear whether these are associated with neurons, or that the modifications are catabolic in nature.] |
||||||
Arylalkylamine N-Acetyltransferase (AA-NAT) | anat-1? | Enzymatic assay | Whole animal | Migliori et al., 2012 | ||
Monoamine Oxidase (MAO) | amx-125 |
Reporter transgenics | ~30 head and tail neurons including ASJ, IL2, other amphid neurons; PHA, PHB, 3 other tail neurons; not expressed in dopaminergic cells. Expressed in nearly all cells in the embryo. | Filkin et al., 2007; Kaushal 2008 | ||
MAO | amx-125 |
Reporter transgenics | 4 pairs amphid neurons: ASJ, and most likely ASH, ASE, AWB,PHA, PHB | Hostettler et al., 2017 | ||
MAO | amx-225 |
Reporter transgenics | Intestine, neurons | Filkin et al., 2007 | ||
Aldehyde Dehydrogenase (ALDH) |
alh-126 | Reporter transgenics | Nervous system, including head neurons, neurons along body, PVT, intestine, head mesodermal cell, rectal gland cells, etc. | McKay et al., 200327 | ||
ALDH |
alh-626 | Reporter transgenics | body wall muscle, hypodermis, unidentified cells in head, unidentified cells in tail (adult) | McKay et al., 200327 | ||
Succinic Semialdehyde Dehydrogenase (SSADH) |
alh-726 | Reporter transgenics | intestine, rectal gland cells, nervous system, head neurons (adult) | McKay et al., 200327 | ||
ALDH |
alh-1026 | Reporter transgenics | intestine, nervous system, tail neurons (adult) | McKay et al., 200327 | ||
Related Mutant Phenotypes / Other Supportive Evidence | ||||||
Dopamine | cat-1, cat-2, cat-4 | Dopamine levels (by HPLC + ED) are reduced to about 40% of wildtype in each of these three mutants. | Sanyal et al., 2004 | |||
TH | cat-2 | Mutant lacks dopamine by FIF; see also 5HT-related phenotypes. | Sulston et al., 1975 | |||
AADC | bas-1 | Mutant lacks dopamine by FIF; Dopaminergic neurons do not become serotonin-immunoreactive with 5HTP treatment; see also 5HT-related phenotypes. | Sawin et al., 2000; Loer & Kenyon, 1993 | |||
AADC | bas-1 | Age-related decline in bas-1 mRNA levels and reporter expression correlate with reduced FIF in CEPs. | Yin et al., 2014 | |||
GTPCH1 | cat-4 | Mutant lacks dopamine by FIF; see also 5HT-related phenotypes. | Sulston et al., 1975; Desai et al., 1988; Loer et al., 2015 | |||
GTPCH1 | cat-4 | Mutant lacks GTPCH1 enzymatic activity. | Loer et al., 2015 | |||
PTPS | ptps-1 | Mutant lacks dopamine by FIF; see also 5HT-related phenotypes. | Loer et al., 2015 | |||
PTPS | ptps-1 | Mutant lacks PTPS enzymatic activity. | Loer et al., 2015 | |||
QDPR | qdpr-1 | Mutant has reduced dopamine by FIF, especially combined with cat-4 reduction-of-function mutation; see also 5HT-related phenotypes. | Loer et al., 2015 | |||
PCBD | pcbd-1 | Mutant has reduced dopamine by FIF, especially combined with cat-4 reduction-of-function mutation; see also 5HT-related phenotypes. | Loer et al., 2015 | |||
VMAT | cat-1 | Dopamine by FIF in mutant is reduced in processes and increased in somas; mutant is phenocopied by reserpine (VMAT blocker). | Sulston et al., 1975 | |||
VMAT | cat-1 | Expression of human VMAT1 or VMAT2 protein in mutant partially rescues behavioral phenotypes, and restores 5HT & dopamine-induced fluorescence (GAIF). | Duerr et al., 1999 | |||
VMAT | cat-1 | Null mutants are deficient in dopamine-mediated behaviors. | Duerr et al., 1999 | |||
DAT | dat-1 | Null mutants lack dopamine uptake in cultured embryonic dopaminergic cells. | Carvelli et al., 2004 | |||
DAT | dat-1 | Mutants are protected from 6-OHDA-induced dopamine neuron degeneration, consistent with role of DAT-1 in dopamine uptake. | Nass et al., 2001; Nass et al., 2005 | |||
DAT | dat-1 | Mutants display 'swimming induced paralysis' (SWIP) phenotype consistent with excess extrasynaptic dopamine; SWIP is reduced by pretreatment with reserpine, and abolished in cat-2; dat-1 double mutant. | McDonald et al., 2007 | |||
SUMMARY - Dopaminergic Neurons (adult): Hermaphrodite (n = 8), Male (n = 14+2)13 By Class: By Class (with numbers and notes): Head: ADE(2), CEP(4) Ventral nerve cord & body: PDE(2) Tail (male only): R5A(2), R7A(2), R9A(2), SPSo(2)13 |
TYRAMINE (TA) and OCTOPAMINE (OA) Summary List of TA & OA neurons | ||||
DESCRIPTION |
GENE NAME | TECHNIQUE FOR DETECTION | LOCALIZATION | REFERENCES |
TA | NA | TLC | Whole animal | Alkema et al., 2005 |
OA | NA | Radioenzymatic assay 28 | Whole animal | Horvitz et al., 1982 |
OA | NA | HPLC + ED | Whole animal | Alkema et al., 2005 |
Synthesis |
||||
Tyrosine Decarboxylase (TDC) | tdc-1 |
Enzymatic assay | Whole animal | Alkema et al., 2005 |
TDC | tdc-1 |
Reporter transgenics, Antibody | RIC, RIM, uv129, gonadal sheath cells | Alkema et al., 2005 |
TDC | tdc-1 |
Reporter transgenics | RIC, RIM, HOA(m), R8A(m)30, R8B(m)30 | Serrano-Saiz et al., 2017 |
Tyramine Beta-Hydroxylase (TBH) | tbh-1 |
Reporter transgenics, Antibody | RIC, gonadal sheath cells | Alkema et al., 2005; Suo et al., 2006 |
Transport - TA and OA are both likely substrates for transport by VMAT | ||||
Vesicular Monoamine Transporter (VMAT)18 | cat-1 | Reporter transgenics | RIC; see also dopaminergic, 5HT neurons | Duerr et al., 1999 |
VMAT | cat-1 | Reporter transgenics (fosmid3) | RIC, RIM, HOA(m); see also DA, 5HT neurons | Serrano-Saiz et al., 2017 |
VMAT | cat-1 |
Antibody19 | RIC; see also dopaminergic, 5HT neurons | Duerr et al., 1999 |
VMAT | cat-1 |
Uptake assay21 | TA and OA are competitive inhibitors of dopamine and 5HT uptake by CAT-1 in heterologous expression (CV-1 cells). | Duerr et al., 1999 |
TA and OA Catabolism
[Note: Monoamine catabolism pathways are only partially characterized in C. elegans. Succinylation appears to be a significant pathway for TA and OA (Artyukhin et al., 2013). TA and OA may also be catabolized via MAO, likely AMX-2. See Dopamine catabolism for further notes on possible monoamine metabolism, and lists of genes that may be involved.] |
||||
Related Mutant Phenotypes / Other Supportive Evidence | ||||
TA | tdc-1 | Mutant lacks TA (by TLC). | Alkema et al., 2005 | |
TA, OA | tdc-1 | Mutant lacks both tyramine- and octopamine succinyl ascarosides. | Artyukhin et al., 2013 | |
TA, OA | tbh-1 | Mutants lacks octopamine succinyl ascarosides; excess succinylated derivative of tyramine is produced. | Artyukhin et al., 2013 | |
OA | tdc-1, tbh-1 | Mutants lacks OA (by HPLC+ ED). | Alkema et al., 2005 | |
TDC | tdc-1 | TDC enzymatic activity is absent or strongly reduced. | Alkema et al., 2005 | |
SUMMARY - Tyraminergic Neurons (adult): Hermaphrodite (n = 2), Male (n = 3 - 730) By Class (with numbers and notes): HOA(m), possibly R8A(2, m), R8B(2, m)30, RIM(2)29, uv1(4, h) (non-neuronal)
By Body Region: SUMMARY - Octopaminergic Neurons (adult): Hermaphrodite (n = 2), Male (n = 2) By Class: RIC
By Body Region: |
SEROTONIN (5HT, 5-hydroxytryptamine) Summary List of 5HT neurons | ||||||
DESCRIPTION |
GENE NAME | TECHNIQUE FOR DETECTION | LOCALIZATION | REFERENCES | ||
5HT | NA | HPLC + ED | Whole animal | Sanyal et al., 2004 | ||
5HT | NA | HPLC + ED | Whole animal | Wang et al., 2017 | ||
5HT | NA | Formaldehyde induced fluorescence (FIF)31 | NSM | Horvitz et al., 1982 | ||
5HT | NA | Glyoxylic acid induced fluorescence (GAIF)32 | NSM, ADF, AIM, RIH, HSN(h), VC4-5(h) | Duerr et al., 1999 | ||
5HT | NA | Antibody | NSM, ADF, AIM, RIH, HSN(h), VC4-5(h)33, CA1-4(m)34, CP1-6(m), RPAG(m)36, R1B(m), R3B(m), R9B(m) | Desai et al., 1988; Loer & Kenyon, 1993; Duerr et al., 1999; Jia & Emmons, 2006 | ||
5HT | NA | Antibody | ASG 23 | Pocock & Hobert, 2010 | ||
5HT | NA | Antibody | Extracellular 5HT-immunoreactivity observed following optogenetic stimulation of NSM, ADF [traditional criterion - stimulation-dependent release]. | Tatum et al., 2015 | ||
5HT | NA | Antibody | NSM, ADF, AIM4, 35, RIH, URX(weak)35, I5 (weak)35, CEM(m, weak)35, HSN(h), CP1-6(m), PGA(m)36, PVX(male only, weak)37, R1B(m, weak), R3B(m), R9B(m) | Serrano-Saiz et al., 2017 | ||
Synthesis |
||||||
Tryptophan Hydroxylase (TPH) | tph-1 |
Reporter transgenics | NSM, ADF, [AIM, RIH]39, HSN(h), CP1-6(m), R1B(m), R3B(m), R9B(m) | Sze et al., 2000 | ||
TPH | tph-1 | Reporter transgenics | ASG38 | Pocock & Hobert, 2010 | ||
TPH | tph-1 |
Reporter transgenics (fosmid3) | NSM, ADF, HSN(h), CP1-6(m), R1B(m), R3B(m), R9B(m) | Serrano-Saiz et al., 2017 | ||
TPH | tph-1 | Reporter transgenics | VC4,5(h) | Mondal et al., 2018 | ||
Aromatic L-Amino Acid Decarboxylase (AADC)14 | bas-1 |
Reporter transgenics | NSM, ADF, [AIM, RIH]39, HSN(h), CP1-6(m), R1B(m), R3B(m), R9B(m); see also dopaminergic neurons |
Hare & Loer, 2004; Flames & Hobert, 2009 | ||
BH4 Cofactor Synthesis and Regeneration
|
||||||
GTP |
cat-4 |
Reporter transgenics | NSM, ADF, HSN(h), CP1-6(m), R1B(m), R3B(m), R9B(m); see also dopaminergic neurons | Sze et al., 2002 ; Flames & Hobert, 2009 | ||
Pyruvoyl Tetrahydropterin Synthase (PTPS) | ptps-1 |
Reporter transgenics | NSM, ADF, HSN(h), VC4-5(h), other unidentified cells; see also dopaminergic neurons | Zhang et al., 2014; Loer et al., 2015 | ||
Pterin Carbinolamine Dehydratase (PCBD) | pcbd-116 |
Reporter transgenics | various unidentified neurons and non-neuronal cells; see also dopaminergic neurons | Zhang et al., 2014; Loer et al., 2015 | ||
Quinoid Dihydropterin Reductase (QDPR) | qdpr-116 |
Reporter transgenics | NSM, ADF, other unidentified cells; see also dopaminergic neurons | Zhang et al., 2014; Loer et al., 2015 | ||
Transport | ||||||
Vesicular Monoamine Transporter (VMAT)18 | cat-1 |
Antibody19 | NSM, ADF, AIM, male VNC & tail cells; see also dopaminergic neurons | Duerr et al., 1999 | ||
VMAT | cat-1 |
Reporter transgenics | NSM, ADF, AIM40, RIH, HSN(h), VC4-5(h), CP1-6(m), RPAG(m)36, R1B(m), R3B(m), R9B(m); see also dopaminergic, OA and TA neurons | Duerr et al., 1999; Nurrish et al., 1999; Duerr et al., 2001; Flames & Hobert, 2009 | ||
VMAT | cat-1 |
Reporter transgenics (fosmid3) | NSM, ADF, RIH, HSN(h), CP1-6(m), PGA(m, weak), PVW(male only, weak)37, R1B(m), R3B(m), R9B(m); see also dopaminergic, OA and TA neurons | Serrano-Saiz et al., 2017 | ||
VMAT | cat-1 |
Uptake assay21 | NA - heterologous expression (CV-1 cells) | Duerr et al., 1999 | ||
Serotonin Reuptake Transporter (SERT) | mod-5 |
Reporter transgenics | NSM, ADF, AIM, RIH, other neuronal and non-neuronal cells | Jafari et al., 2011; Barrière et al., 2014 | ||
SERT | mod-5 |
Antibody | NSM, AIM | Jafari et al., 2011 | ||
SERT | mod-5 |
Uptake assay41 | NA - heterologous expression (HEK293 cells) | Ranganathan et al., 2001 | ||
Catabolism |
||||||
Serotonin N-Acetyltransferase (SNAT) | anat-1? | Enzymatic assay | Whole animal | Muimo & Isaacs, 1993 | ||
Arylalkylamine N-Acetyltransferase (AA-NAT) | anat-1?42 | Enzymatic assay | Whole animal | Migliori et al., 2012 | ||
Monoamine Oxidase (MAO) | amx-125 | Reporter transgenics | ~30 head and tail neurons including ASJ, IL2, other amphid neurons; PHB, 3 other tail neurons | Filkin et al., 2007; Kaushal 2008 | ||
MAO | amx-225 | Reporter transgenics | Intestine, neurons |
Filkin et al., 2007 | ||
MAO | amx-225 | Reporter transgenics | Pharynx, intestine, vulval cells, rectal epithelial cells | Schmid et al., 2015 | ||
MAO | amx-225 | Reporter transgenics | Pharyngeal muscle, intestine, NSM, other head neurons, vulva, HSN(h), anus |
Wang et al., 2017 | ||
Aldehyde Dehydrogenase (ALDH) |
alh-126 |
Reporter transgenics | Nervous system, including head neurons, neurons along body, PVT, intestine, head mesodermal cell, rectal gland cells, etc. | McKay et al., 200327 | ||
Related Mutant Phenotypes / Other Supportive Evidence | ||||||
TPH | tph-1 | Mutant lacks serotonin immunoreactivity (5HT-IR). | Sze et al., 2000 | |||
GTPCH1 | cat-4 | Mutant lacks 5HT-IR (or is greatly reduced); see also dopamine-related phenotypes. | Desai et al., 1988; Loer & Kenyon, 1993; Loer et al., 2015 | |||
PTPS | ptps-1 | Mutant lacks 5HT-IR; see also dopamine-related phenotypes. | Loer et al., 2015 | |||
QDPR | qdpr-1 | Mutant has reduced 5HT-IR, especially combined with cat-4 reduction-of-function mutation; see also dopamine-related phenotypes. | Loer et al., 2015 | |||
PCBD | pcbd-1 | Mutant has reduced 5HT-IR, especially combined with cat-4 reduction-of-function mutation; see also dopamine-related phenotypes. | Loer et al., 2015 | |||
AADC | bas-1 | Mutant lacks 5HT-IR (or is greatly reduced); 5HT-IR rescued by exogenous 5HT but not 5HTP (5-hydroxytryptophan); see also dopamine-related phenotypes. | Loer & Kenyon, 1993; Weinshenker et al., 1995; Sawin et al., 2000; Jafari et al., 2011 | |||
AADC | bas-1 | Age-related decline in bas-1 mRNA levels and reporter expression correlate with reduced NSM 5HT-IR. | Yin et al., 2014 | |||
VMAT | cat-1 | Mutant lacks serotonin FIF in NSM processes, but shows increased FIF in somas; reduced 5HT-IR. | Horvitz et al., 1982; Loer & Kenyon, 1993 | |||
VMAT | cat-1 | Expression of human VMAT1 or VMAT2 protein in mutant partially rescues behavioral phenotypes, and restores 5HT & dopamine induced fluorescence (GAIF). | Duerr et al., 1999 | |||
SERT | mod-5 | Mutant phenotype consistent with increased presynaptic serotonin, phenocopied by serotonin-specific reuptake inhibitors (SSRIs) such as fluoxetine, partially phenocopied by less-specific tricyclics such as imipramine; mutant is hypersensitive to exogenous serotonin. | Ranganathan et al., 2001 | |||
SERT | mod-5 | Mutants lack 5HT-IR in AIM and RIH; fluoxetine or imipramine treatment reduces or eliminates 5HT-IR in AIM and RIH. In mutants, expression of mod-5 cDNA in AIM restores 5HT-IR; expression in other neurons causes ectopic 5HT-IR. | Kullyev et al., 2010; Jafari et al., 2011 | |||
SERT | mod-5 | In tph-1; mod-5 double mutants, addition of 5HT fails to rescue loss of 5HT-IR. [Addition of 5HT in tph-1 single mutants rescues 5HT-IR in many neurons.] | Jafari et al., 2011 | |||
MAO | amx-2 | Mutants have elevated 5HT levels; treatment with 5HIAA rescues altered vulval induction phenotype in mutant. | Schmid et al., 2015 | |||
MAO | amx-2 | Mutants have elevated 5HT levels, and greatly reduced 5HIAA levels. Mutants in grk-2, which elevate AMX-2 levels, have greatly reduced 5HT levels, and greatly elevated 5HIAA levels. | Wang et al., 2017 | |||
SUMMARY - Serotonergic Neurons (adult): Hermaphrodite (n = 11 or 13)38, Male (n = 20 or 22)38
By Class: By Class (with numbers and notes): By Body Region: Other possibly serotonergic neurons (not included in above totals): CA1-4(m)34, CEM(2, m)35, I535, PHB(2)43, URX35 |
GAMMA-AMINOBUTYRIC ACID (GABA, gamma-aminobutyrate) Summary List of GABA neurons | ||||||
DESCRIPTION |
GENE NAME | TECHNIQUE FOR DETECTION | LOCALIZATION | REFERENCES | ||
GABA | NA | Antibody | AVL, DD1-6, DVB , RIS, RME, VD1-13 | McIntire et al., 1993b | ||
GABA | NA | Antibody | ALA44, AVA45, AVB45, AVJ45, AVL, DD1-6, DVB , EF1-4(m), R2A(m), R6A(m), R9B(m), RIB, RIS, RME, SMDD/V45, VD1-13, GLR, hmc, muscle | Gendrel et al., 2016 | ||
GABA | NA | Antibody | CP9(m), EF1-4(m), R2A(m, weak), R6A(m), R9B(m, weak) | Gendrel et al., 2016; Serrano-Saiz et al., 2017 | ||
|
||||||
Glutamatic Acid Decarboxylase (GAD) | unc-25 |
Reporter transgenics | AVL, DD1-6, DVB , RIS, RME, VD1-13 | Jin et al., 1999 | ||
GAD | unc-25 |
Reporter transgenics (CRISPR-endogenous locus3) | AVL, DD1-6, DVB , EF1-4(m), RIB, RIS, RME, VD1-13 | Gendrel et al., 2016 | ||
GAD | unc-25 |
Reporter transgenics (CRISPR-endogenous locus3) | CP9(m) | Serrano-Saiz et al., 2017 | ||
Transport | ||||||
Vesicular GABA Transporter (VGAT) | unc-47 | Reporter transgenics | AVL, DD1-6, DVB , RIS, RME, VD1-13 | McIntire et al., 1997 | ||
VGAT | unc-47 | Reporter transgenics | AVL, DD1-6, DVB , RIS, RME, SIAD, SDQ(weak), VD1-13 | Barrière & Ruvinsky, 2014 | ||
VGAT | unc-47 | Reporter transgenics (fosmid3) |
AVL, DD, DVB , EF1-4(m), R6A(m), RIB, RIS, RME, SMDD/V, VD1-13 | Gendrel et al., 2016 | ||
VGAT | unc-47 | Reporter transgenics (fosmid3) |
CP9(m), EF1-4(m), R2A(m), R6A(m), R9B(m); Sex-shared cells with adult male only expression: ADF, AS10 or DA7, AS11, PCA, PDB, PHC, PVN; Loses expression in adult male: PQR; Cells that express unc-47 reporter but lack GABA-IR (possibly glycinergic?): CA1-9(m)34, CEM(m), CP1-6, CP8(m), DVE(m), DVF(m), HOA(m), PDC(m), PGA(m), PVY(m), PVX(m), PVZ(m), R1A(m), R3A(m), R3B(m), R5A(m), R5B(m), R8A(m), R9B(m), PCB, PCC , SPC(m) |
Serrano-Saiz et al., 2017 | ||
'VGAT Chaperone'46 | unc-46 |
Reporter transgenics | AVL, DD1-6, DVB , RIS, RME, VD1-13, plus a few unidentified neurons | Schuske et al., 2007 | ||
'VGAT Chaperone'46 | unc-46 | Reporter transgenics | AVL, DD1-6, DVB , RIS, RME, SIAD, VD1-13 | Barrière & Ruvinsky, 2014 | ||
'VGAT Chaperone'46 | unc-46 | Reporter transgenics (fosmid3) |
AVL, DD1-6, DVB , EF1-4(m), R9B(m) 47, RIB, RIS, RME, VD1-13 | Gendrel et al., 2016 | ||
GABA Transporter (GAT) | snf-11 |
Reporter transgenics | AVL, [DD1-6,]48 DVB , [PVQ,]48 RIS, RME, [VD1-13]48 | Jiang et al., 2005 | ||
GAT | snf-11 |
Reporter transgenics, antibody | AVL, DVB, RID, RIS, RME, 2 neurons in pharynx, 2 neurons in RVG, muscles (body wall, anal, uterine)48 | Mullen et al., 2006 | ||
GAT | snf-11 |
Reporter transgenics (fosmid3) | ALA44, AVF, AVL, RIB, RME, VD12(m)49, GLR, hmc, muscle | Gendrel et al., 2016 | ||
GAT | snf-11 |
Reporter transgenics (fosmid3) | CP9(m)49 | Serrano-Saiz et al., 2017 | ||
GAT | snf-11 | Uptake assay50 | NA - heterologous expression (HRPE cells and Xenopus oocyte) | Jiang et al., 2005 | ||
GAT | snf-11 | Uptake assay50 | NA - heterologous expression (Xenopus oocyte) | Mullen et al., 2006 | ||
Catabolism [Note: GABA catabolism has not been characterized in C. elegans. Although both GABA-T and SSADH (see below) are important in GABA catabolism in the mammalian brain (Tillakaratne et al., 1995), there is currently no evidence they serve the same functions in C. elegans (i.e., no revealing mutant phenotypes), but see below regarding recent gta-1 (GABA-T orthologous gene) expression data. Also, GABA-T transfers an amino group from GABA to α-Ketoglutarate to form Glutamate and SSA, so this reaction is also a potential source of glutamate. See also note26 regarding putative aldehyde dehydrogenases other than SSADH.] |
||||||
GABA Transaminase (GABA-T) | gta-1 |
Reporter transgenics | Body wall muscle, head neurons, unidentified cells | McKay et al., 200327; Meissner et al., 2011 | ||
GABA Transaminase (GABA-T) | gta-1 |
Reporter transgenics (fosmid3) | Ubiquitous51 | Gendrel et al., 2016 | ||
Succinic Semialdehyde Dehydrogenase (SSADH) | alh-726 |
Reporter transgenics | Intestine, rectal gland cells, hypodermis, nervous system, head neurons | McKay et al., 200327 | ||
Related Mutant Phenotypes / Other Supportive Evidence | ||||||
GAD | unc-25 | Mutant lacks GABA immunoreactivity; mutant has 'shrinker' phenotype. | McIntire et al., 1993b | |||
VGAT | unc-47 | Mutant has 'shrinker' phenotype characteristic of GABA loss of function, but elevated cellular GABA immunoreactivity. | McIntire et al., 1997 | |||
VGAT Chaperone | unc-46 | Mutant has 'shrinker' phenotype. | McIntire et al., 1993b; Schuske et al., 2007 | |||
GAT | snf-11 | Mutants show GABA-dependent aldicarb resistance. | Mullen et al., 2006 | |||
GAT | snf-11 | GABA-dependent behaviors are not rescued by exogenous GABA in unc-25; snf-11 double mutants. | Mullen et al., 2006 | |||
GAT | snf-11 | Mutants fail to uptake GABA in cultured embryonic cells. | Mullen et al., 2006 | |||
SUMMARY - GABAergic Neurons (adult): Hermaphrodite (n = 32), Male (n = 43)
By Class: By Class (with numbers and notes): By Body Region: Other possibly GABAergic neurons (not included in above totals): AVA , AVB, AVJ; possible 'GABA clearance' neurons: ALA, AVF |
GLUTAMATE (Glu, Glutamic Acid) Summary List of Glu neurons | ||||||
| ||||||
DESCRIPTION |
GENE NAME | TECHNIQUE FOR DETECTION | LOCALIZATION | REFERENCES | ||
Transport | ||||||
Vesicular Glutamate Transporter (VGluT) | eat-452 |
Reporter transgenics | M3, I5, ADA, ALM, ASH, ASK, AUA, AVM, FLP, IL1, LUA, OLL, OLQ, PLM, PVD, PVR | Lee et al., 1999; Mano et al., 2007 | ||
VGluT | eat-452 |
Reporter transgenics | Many head neurons, including ADL, AFD, AIB, AIM, AIZ, ASH, ASE, ASG, ASK, AUA, AVA, AVE, AWB, AWC, RIA, etc. | Ohnishi et al., 2011 | ||
VGluT | eat-452 |
Reporter transgenics (fosmid3) | M3, MI, I2, I5, ADA, ADL, AFD, AIB, AIM, AIZ, ALM, AQR, ASE, ASG, ASH, ASK, AUA, AVM, AWC, BAG, DVC, FLP, IL1, LUA, OLL, OLQ, PHA, PHB, PHC, PLM, PQR, PVD, PVQ, PVR, RIA, RIG, RIM, URY, 20 more male-specific cells (see below) | Serrano-Saiz et al., 2013 | ||
VGluT | eat-452 |
Reporter transgenics (fosmid3) | Male-specific cells only: CP0(m, weak), CP5(m, weak), CP6(m, weak), CP7(m), HOA(m), PCA(m), PVV(m), R2B (m, weak), R5A(m), R6B (m, weak), R9A (m, weak) | Serrano-Saiz et al., 2017 | ||
VGluT | vglu-253 |
Reporter transgenics (fosmid3) | AIA, skin cells | Serrano-Saiz et al., 2019 | ||
Plasma Membrane Glutamate Transporter (PmGluT) | glt-154 |
Reporter transgenics | Muscle, hypodermis | Mano et al., 2007 | ||
PmGluT | glt-3 |
Reporter transgenics | Excretory canal cell, pharynx | Mano et al., 2007 | ||
PmGluT | glt-455 |
Reporter transgenics | AUA, RIA, IL2 | Mano et al., 2007 | ||
PmGluT | glt-5 |
Reporter transgenics | Pharynx | Mano et al., 2007 | ||
PmGluT | glt-6 |
Reporter transgenics | Excretory canal cell, pharynx marginal cells | Reported27 in Mano et al., 2007 | ||
PmGluT | glt-7 |
Reporter transgenics | Excretory canal cell | Mano et al., 2007 | ||
Related Mutant Phenotypes / Other Supportive Evidence | ||||||
VGluT | eat-4 | Mutant has pharyngeal phenotypes similar to glutamate receptor avr-15 mutant, but pharynx responds normally to exogenous Glu, indicating presynaptic function. | Dent et al., 1997 | |||
VGluT | eat-4 | Mutant phenotypes (hyperactive foraging, reduced pharyngeal pumping rate) are rescued by expression of human VGluT via eat-4 promoter. | Lee et al., 2008 | |||
PmGluT | glt-1 - glt-7 | Individual glt mutants have increased Glu-dependent behaviors. | Mano et al., 2007 | |||
PmGluT | glt-3, glt-4, glt-6 glt-3, glt-4, glt-7 |
Triple glt mutants have strongly increased Glu-dependent behaviors. | Mano et al., 2007 | |||
SUMMARY - Glutamatergic Neurons (adult): Hermaphrodite (n = 79), Male (n = ~98)
By Class: By Class (with numbers and notes): By Body Region: |
Neurons currently lacking classical neurotransmitter assignments (list taken from Serrano-Saiz et al., 2017):
Sex-shared neurons: ASI, AVF, AVH, AVJ,
AVK, AWA, BDU, CAN20, PVM, PVT, PVW [only in hermaphrodites], RID, RIP, RMG, I4, and I6 |
Notes 1 The genes unc-17 and cha-1 are coexpressed in an operon, controlled by a single promoter upstream of unc-17 (Alfonso et al., 1994a). |
Acknowledgements and General References:
We thank Oliver Hobert for extensive comments and suggestions; members of the Hobert lab (some now former) Marie Gendrel, Laura Pereira and Esther Serrano-Saiz; also Nate Schroeder for other comments and corrections. Thanks to Alec Knapp and Daniel Sykora (Loer lab) for help in proof-reading information and links in the table (2016 version).
Beside primary sources listed in the table above, other sites and reviews of C. elegans literature were helpful in assembling this information, including the following:
See here for information on the Criteria for assigning a neurotransmitter function in C. elegans.
To see all monoamine synthesis and degradation pathways refer to Monoamine Pathways Chart.
How to Cite this document:
This section should be cited as: Loer, CM§ & Rand, JB (2022). The Evidence for Classical Neurotransmitters in C. elegans Neurons, in WormAtlas. DOI pending.
§To whom correspondence should be addressed. Curtis Loer: cloer@sandiego.edu